Vigil Neuroscience (VIGL) Competitors $3.02 -0.03 (-0.98%) (As of 01:52 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VIGL vs. MGTX, RGNX, AURA, ALLO, TSHA, SGMO, PRME, VALN, DNA, and FDMTShould you be buying Vigil Neuroscience stock or one of its competitors? The main competitors of Vigil Neuroscience include MeiraGTx (MGTX), REGENXBIO (RGNX), Aura Biosciences (AURA), Allogene Therapeutics (ALLO), Taysha Gene Therapies (TSHA), Sangamo Therapeutics (SGMO), Prime Medicine (PRME), Valneva (VALN), Ginkgo Bioworks (DNA), and 4D Molecular Therapeutics (FDMT). These companies are all part of the "biological products, except diagnostic" industry. Vigil Neuroscience vs. MeiraGTx REGENXBIO Aura Biosciences Allogene Therapeutics Taysha Gene Therapies Sangamo Therapeutics Prime Medicine Valneva Ginkgo Bioworks 4D Molecular Therapeutics MeiraGTx (NASDAQ:MGTX) and Vigil Neuroscience (NASDAQ:VIGL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk, media sentiment and community ranking. Does the MarketBeat Community prefer MGTX or VIGL? MeiraGTx received 164 more outperform votes than Vigil Neuroscience when rated by MarketBeat users. However, 81.82% of users gave Vigil Neuroscience an outperform vote while only 71.54% of users gave MeiraGTx an outperform vote. CompanyUnderperformOutperformMeiraGTxOutperform Votes19171.54% Underperform Votes7628.46% Vigil NeuroscienceOutperform Votes2781.82% Underperform Votes618.18% Is MGTX or VIGL more profitable? Vigil Neuroscience has a net margin of 0.00% compared to MeiraGTx's net margin of -633.05%. Vigil Neuroscience's return on equity of -83.89% beat MeiraGTx's return on equity.Company Net Margins Return on Equity Return on Assets MeiraGTx-633.05% -146.38% -53.05% Vigil Neuroscience N/A -83.89%-65.34% Do analysts prefer MGTX or VIGL? MeiraGTx currently has a consensus price target of $23.50, indicating a potential upside of 293.63%. Vigil Neuroscience has a consensus price target of $16.80, indicating a potential upside of 456.29%. Given Vigil Neuroscience's higher possible upside, analysts clearly believe Vigil Neuroscience is more favorable than MeiraGTx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MeiraGTx 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Vigil Neuroscience 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Do institutionals & insiders hold more shares of MGTX or VIGL? 67.5% of MeiraGTx shares are held by institutional investors. Comparatively, 83.6% of Vigil Neuroscience shares are held by institutional investors. 8.4% of MeiraGTx shares are held by insiders. Comparatively, 33.0% of Vigil Neuroscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk & volatility, MGTX or VIGL? MeiraGTx has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500. Comparatively, Vigil Neuroscience has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. Which has higher earnings and valuation, MGTX or VIGL? Vigil Neuroscience has lower revenue, but higher earnings than MeiraGTx. MeiraGTx is trading at a lower price-to-earnings ratio than Vigil Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeiraGTx$14.02M33.28-$84.03M-$1.21-4.93Vigil NeuroscienceN/AN/A-$82.64M-$2.06-1.47 Does the media refer more to MGTX or VIGL? In the previous week, MeiraGTx had 7 more articles in the media than Vigil Neuroscience. MarketBeat recorded 7 mentions for MeiraGTx and 0 mentions for Vigil Neuroscience. Vigil Neuroscience's average media sentiment score of 0.00 beat MeiraGTx's score of -0.17 indicating that Vigil Neuroscience is being referred to more favorably in the news media. Company Overall Sentiment MeiraGTx Neutral Vigil Neuroscience Neutral SummaryVigil Neuroscience beats MeiraGTx on 11 of the 17 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get Vigil Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIGL vs. The Competition Export to ExcelMetricVigil NeuroscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$123.46M$2.98B$5.10B$8.84BDividend YieldN/A1.91%5.04%4.07%P/E Ratio-1.4719.4095.1214.22Price / SalesN/A286.461,217.3088.42Price / CashN/A169.3839.4936.27Price / Book1.394.486.976.37Net Income-$82.64M-$41.63M$118.73M$225.56M7 Day Performance-5.03%-3.93%-1.22%-0.02%1 Month Performance-21.35%-5.61%-3.07%2.04%1 Year Performance-7.65%27.32%32.52%28.00% Vigil Neuroscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIGLVigil Neuroscience3.2362 of 5 stars$3.02-1.0%$16.80+456.3%-16.4%$123.46MN/A-1.4764MGTXMeiraGTx4.3446 of 5 stars$5.97+2.6%$23.50+293.6%+2.8%$466.56M$14.02M0.00300Analyst ForecastRGNXREGENXBIO4.4239 of 5 stars$9.35-2.9%$35.27+277.2%-51.9%$463.20M$90.24M-1.91344Analyst ForecastAnalyst RevisionGap DownAURAAura Biosciences3.543 of 5 stars$9.00+2.9%$23.00+155.6%+5.3%$449.55MN/A-5.0650Insider TradeAnalyst RevisionALLOAllogene Therapeutics2.7998 of 5 stars$2.12+3.4%$9.73+359.1%-31.4%$444.50M$90,000.000.00232Short Interest ↓TSHATaysha Gene Therapies3.935 of 5 stars$2.14+6.5%$6.63+209.6%+11.7%$438.57M$15.45M3.19180SGMOSangamo Therapeutics2.1854 of 5 stars$1.99+1.8%$7.00+252.6%+369.9%$414.17M$176.23M0.00480Analyst RevisionPRMEPrime Medicine3.0774 of 5 stars$3.02+1.0%$13.25+338.7%-57.0%$396.10MN/A-1.46234Analyst RevisionVALNValneva2.2966 of 5 stars$4.56-2.4%$18.50+305.7%-62.1%$370.50M$165.52M-33.54700Gap DownDNAGinkgo Bioworks1.1472 of 5 stars$6.65+4.6%$4.58-31.2%N/A$369.61M$251.46M0.001,218Short Interest ↓FDMT4D Molecular Therapeutics3.0113 of 5 stars$7.97-5.2%$42.13+428.5%-32.1%$368.45M$20.72M-2.80201Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies MGTX Competitors RGNX Competitors AURA Competitors ALLO Competitors TSHA Competitors SGMO Competitors PRME Competitors VALN Competitors DNA Competitors FDMT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VIGL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vigil Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vigil Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIGL Stock Alerts